Chiron to Hold Investor Conference Call to Discuss FLUVIRIN Influenza Virus Vaccine License Reinstatement; Thursday, March 3, at 8:30 a.m. PST.EMERYVILLE, Calif. -- Chiron Corporation (Nasdaq:CHIR CHIR Chiricahua National Monument (US National Park Service) ) will host a conference call and audio webcast on Thursday, March 3, at 8:30 a.m. PST PST Paroxysmal supraventricular tachycardia, see there to discuss the company's announcement that the UK Medicines and Healthcare products Regulatory Agency The Medicines and Healthcare products Regulatory Agency (MHRA) is the UK government agency which is responsible for ensuring that medicines and medical devices work and are acceptably safe. (MHRA MHRA Medicines and Healthcare Products Regulatory Agency MHRA Modern Humanities Research Association (United Kingdom) MHRA Minnesota Human Rights Act MHRA Malta Hotels and Restaurants Association ) has lifted the license suspension for Chiron's Liverpool manufacturing facility, which produces FLUVIRIN(R) influenza virus vaccine influenza virus vaccine n. A vaccine containing influenza virus, usually several strains of the virus, prepared in chick embryos and used to immunize against influenza. . To access either the live conference call or the one-week archive, please log on to www.chiron.com/webcast. Please connect to the website at least 15 minutes prior to the conference call to ensure adequate time to download any necessary software. Alternatively, please call (800) 819-7026 from the United States or Canada or (706) 643-7768 from other locations. Replay is available approximately two hours after the completion of the call through 11:55 p.m. EST, Thursday, March 10, 2005. To access the replay, please call (800) 642-1687 from the United States or Canada or (706) 645-9291 from other locations. The conference ID number is 4530966. About Chiron Chiron delivers innovative and valuable products to protect human health by advancing pioneering science across the landscape of biotechnology. The company works to deliver on the limitless promise of science and make a positive difference in people's lives. For more information, please visit www.chiron.com. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion